- Home
- NEXT vs ALVO Comparison
NEXT vs ALVO Comparison
Compare NEXT & ALVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NEXT
- ALVO
- Stock Information
- Founded
- NEXT 2010
- ALVO 2013
- Country
- NEXT United States
- ALVO Luxembourg
- Employees
- NEXT N/A
- ALVO N/A
- Industry
- NEXT Oil & Gas Production
- ALVO Biotechnology: Pharmaceutical Preparations
- Sector
- NEXT Energy
- ALVO Health Care
- Exchange
- NEXT Nasdaq
- ALVO Nasdaq
- Market Cap
- NEXT 2.9B
- ALVO 2.5B
- IPO Year
- NEXT N/A
- ALVO N/A
- Fundamental
- Price
- NEXT $10.69
- ALVO $8.33
- Analyst Decision
- NEXT Buy
- ALVO
- Analyst Count
- NEXT 1
- ALVO 0
- Target Price
- NEXT $15.00
- ALVO N/A
- AVG Volume (30 Days)
- NEXT 2.4M
- ALVO 486.2K
- Earning Date
- NEXT 08-01-2025
- ALVO 08-13-2025
- Dividend Yield
- NEXT N/A
- ALVO N/A
- EPS Growth
- NEXT N/A
- ALVO N/A
- EPS
- NEXT N/A
- ALVO 0.22
- Revenue
- NEXT N/A
- ALVO $562,478,000.00
- Revenue This Year
- NEXT N/A
- ALVO $33.32
- Revenue Next Year
- NEXT N/A
- ALVO $46.16
- P/E Ratio
- NEXT N/A
- ALVO $37.86
- Revenue Growth
- NEXT N/A
- ALVO 82.19
- 52 Week Low
- NEXT $4.27
- ALVO $7.35
- 52 Week High
- NEXT $12.12
- ALVO $13.70
- Technical
- Relative Strength Index (RSI)
- NEXT 55.40
- ALVO 48.09
- Support Level
- NEXT $10.52
- ALVO $7.85
- Resistance Level
- NEXT $11.27
- ALVO $8.12
- Average True Range (ATR)
- NEXT 0.50
- ALVO 0.27
- MACD
- NEXT 0.03
- ALVO 0.01
- Stochastic Oscillator
- NEXT 69.95
- ALVO 39.47
About NEXT NextDecade Corporation
NextDecade Corp is a Houston-based energy company engaged in construction and development activities related to the liquefaction of natural gas and sale of LNG and the capture and storage of CO2 emissions. The group is constructing and developing a natural gas liquefaction and export facility located in the Rio Grande Valley near Brownsville, Texas (the Rio Grande LNG Facility). It also engaged in NEXT Carbon Solutions advancing proprietary processes to lower the cost of utilizing carbon capture and storage (CCS) and help companies reduce their emissions and achieve their clean energy goals.
About ALVO Alvotech
Alvotech is an integrated biopharmaceutical company committed to developing and manufacturing high-quality biosimilar medicines for patients globally. its purpose is to improve the health and quality of life of patients around the world by improving access to treatments for various diseases.